Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| 1 |
Invesco S&P 500 Revenue ETF
RWL
|
+$658M |
| 2 |
Tesla
TSLA
|
+$573M |
| 3 |
Bank of America
BAC
|
+$480M |
| 4 |
Amazon
AMZN
|
+$448M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$445M |
Top Sells
| 1 |
Invesco S&P 500 Pure Value ETF
RPV
|
+$493M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$395M |
| 3 |
Eli Lilly
LLY
|
+$364M |
| 4 |
CME Group
CME
|
+$316M |
| 5 |
T-Mobile US
TMUS
|
+$310M |
Sector Composition
| 1 | Technology | 23.42% |
| 2 | Financials | 13.31% |
| 3 | Industrials | 11.27% |
| 4 | Healthcare | 10.55% |
| 5 | Consumer Discretionary | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3426
Achieve Life Sciences
ACHV
$157M
| $197K | ﹤0.01% |
73,644
+56,856
| +339% | +$152K |
|
3427
Standard BioTools
LAB
$489M
| $196K | ﹤0.01% |
181,639
+6,598
| +4% | +$7.13K |
|
3428
Calumet Specialty Products
CLMT
$1.51B
| $195K | ﹤0.01% |
15,395
-28,674
| -65% | -$364K |
|
3429
Vera Bradley
VRA
$65.4M
| $195K | ﹤0.01% |
86,512
-9,409
| -10% | -$21.2K |
|
3430
Forrester Research
FORR
$189M
| $194K | ﹤0.01% |
21,049
-2,478
| -11% | -$22.9K |
|
|
BCAX
3431
Bicara Therapeutics Inc. Common Stock
BCAX
$668M
| $194K | ﹤0.01% |
14,915
-409
| -3% | -$5.33K |
|
3432
iShares MSCI Hong Kong ETF
EWH
$729M
| $193K | ﹤0.01% |
11,024
+143
| +1% | +$2.5K |
|
3433
Betterware México
BWMX
$510M
| $192K | ﹤0.01% |
16,854
-4,485
| -21% | -$51K |
|
3434
Olema Pharmaceuticals
OLMA
$520M
| $191K | ﹤0.01% |
50,810
+34,362
| +209% | +$129K |
|
3435
Immunome
IMNM
$820M
| $191K | ﹤0.01% |
28,379
+1,718
| +6% | +$11.6K |
|
3436
Ivanhoe Electric
IE
$1.21B
| $188K | ﹤0.01% |
32,427
-2,725,895
| -99% | -$15.8M |
|
3437
Babcock & Wilcox
BW
$245M
| $188K | ﹤0.01% |
279,373
-86,719
| -24% | -$58.3K |
|
3438
ADC Therapeutics
ADCT
$372M
| $187K | ﹤0.01% |
132,704
+98,335
| +286% | +$139K |
|
|
JBIO
3439
Jade Biosciences, Inc. Common Stock
JBIO
$250M
| $187K | ﹤0.01% |
+2,127
| New | +$187K |
|
|
REFI
3440
Chicago Atlantic Real Estate Finance
REFI
$288M
| $185K | ﹤0.01% |
+12,618
| New | +$185K |
|
3441
Real Brokerage
REAX
$1.07B
| $185K | ﹤0.01% |
45,542
-1,723
| -4% | -$7K |
|
3442
Skillz
SKLZ
$114M
| $185K | ﹤0.01% |
41,052
-11,308
| -22% | -$50.9K |
|
3443
Domo
DOMO
$649M
| $183K | ﹤0.01% |
23,624
+12,722
| +117% | +$98.7K |
|
3444
Bakkt Holdings
BKKT
$134M
| $183K | ﹤0.01% |
21,080
+6,717
| +47% | +$58.2K |
|
3445
Alector
ALEC
$285M
| $183K | ﹤0.01% |
148,576
+100,591
| +210% | +$124K |
|
3446
TaskUs
TASK
$1.54B
| $182K | ﹤0.01% |
+13,374
| New | +$182K |
|
|
BORR
3447
Borr Drilling
BORR
$847M
| $182K | ﹤0.01% |
83,044
-6,396
| -7% | -$14K |
|
3448
Codexis
CDXS
$220M
| $181K | ﹤0.01% |
67,447
+33,716
| +100% | +$90.7K |
|
3449
PLAYSTUDIOS Inc
MYPS
$120M
| $181K | ﹤0.01% |
142,381
-26,995
| -16% | -$34.3K |
|
3450
Cemex
CX
$13.8B
| $180K | ﹤0.01% |
32,132
| – | – |
|